Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Stroke

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 285 articles: HTML format

Single Articles

September 2021
1. SPARROW RT, Sanjoy SS, Lindman BR, Tang GHL, et al
   Racial, ethnic and socioeconomic disparities in patients undergoing transcatheter mitral edge-to-edge repair.
   Int J Cardiol. 2021 Sep 20. pii: S0167-5273(21)01478.
   PubMed     Abstract available
   
   
   
2. AIT-OUFELLA H, Yu M, Kotti S, Georges A, et al
   Plasma and genetic determinants of soluble TREM-1 and major adverse cardiovascular events in a prospective cohort of acute myocardial infarction patients. Results from the FAST-MI 2010 study.
   Int J Cardiol. 2021 Sep 15. pii: S0167-5273(21)01379.
   PubMed     Abstract available
   
   
   
3. AL-RUBAISH AM, Al-Muhanna FA, Alshehri AM, Al-Mansori MA, et al
   Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
   Int J Cardiol. 2021 Sep 10. pii: S0167-5273(21)01319.
   PubMed     Abstract available
   
   
   August 2021
4. WANG W, Liu Y, Liu J, Yin P, et al
   Mortality and years of life lost of cardiovascular diseases in China, 2005-2020: Empirical evidence from national mortality surveillance system.
   Int J Cardiol. 2021 Aug 25. pii: S0167-5273(21)01300.
   PubMed     Abstract available
   
   
   
5. PICARD F, Bhatt DL, Ducrocq G, Ohman EM, et al
   Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) reg
   Int J Cardiol. 2021 Aug 24. pii: S0167-5273(21)01297.
   PubMed     Abstract available
   
   
   
6. SEN J, Tonkin A, Varigos J, Fonguh S, et al
   Risk stratification of cardiovascular complications using CHA2DS2-VASc and CHADS2 scores in chronic atherosclerotic cardiovascular disease.
   Int J Cardiol. 2021;337:9-15.
   PubMed     Abstract available
   
   
   
7. ZUIN M, Rigatelli G
   Thrombus straddling a patent foramen ovale: Also a myocardial infarction matter?
   Int J Cardiol. 2021 Aug 7. pii: S0167-5273(21)01206.
   PubMed    
   
   
   July 2021
8. JAMAL J, O'Loughlin A, French JK
   A fibrinolysis-first strategy for ST-elevation myocardial infarction in the COVID-19 era.
   Int J Cardiol. 2021 Jul 31. pii: S0167-5273(21)01210.
   PubMed    
   
   
   
9. MATETIC A, Mohamed M, Miller RJH, Kolman L, et al
   Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions.
   Int J Cardiol. 2021 Jul 29. pii: S0167-5273(21)01197.
   PubMed     Abstract available
   
   
   
10. JACOBSEN MR, Engstrom T, Torp-Pedersen C, Gislason G, et al
    Clopidogrel, prasugrel, and ticagrelor for all-comers with ST-segment elevation myocardial infarction.
    Int J Cardiol. 2021 Jul 23. pii: S0167-5273(21)01192.
    PubMed     Abstract available
    
    
    
11. VEDOVATI MC, Tratar G, Mavri A, Mazzetti M, et al
    Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01099.
    PubMed     Abstract available
    
    
    
12. SHAH P, Jimenez-Ruiz A, Gibson A, Vargas-Gonzalez JC, et al
    Association between acute myocardial infarction and death in 386 patients with a thrombus straddling a patent foramen ovale.
    Int J Cardiol. 2021 Jul 7. pii: S0167-5273(21)01101.
    PubMed     Abstract available
    
    
    June 2021
13. VAN DER MATEN G, Dijkstra S, Meijs MFL, von Birgelen C, et al
    Cardiac imaging in ischemic stroke or transient ischemic attack of undetermined cause: Systematic review & meta-analysis.
    Int J Cardiol. 2021 Jun 28. pii: S0167-5273(21)01083.
    PubMed     Abstract available
    
    
    
14. FAROUX L, Cruz-Gonzalez I, Arzamendi D, Freixa X, et al
    Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
    Int J Cardiol. 2021;333:77-82.
    PubMed     Abstract available
    
    
    May 2021
15. JANSSENS GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, et al
    Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome.
    Int J Cardiol. 2021 May 15. pii: S0167-5273(21)00830.
    PubMed     Abstract available
    
    
    
16. MINHAS A, Shade JK, Cho SM, Michos ED, et al
    The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.
    Int J Cardiol. 2021 May 8. pii: S0167-5273(21)00823.
    PubMed     Abstract available
    
    
    
17. MANNINA C, Jin Z, Matsumoto K, Ito K, et al
    Frequency of cardiac arrhythmias in older adults: Findings from the Subclinical Atrial Fibrillation and Risk of Ischemic Stroke (SAFARIS) study.
    Int J Cardiol. 2021 May 6. pii: S0167-5273(21)00818.
    PubMed     Abstract available
    
    
    
18. MIRO O, Llorens P, Jimenez S, Pinera P, et al
    Frequency of five cardiovascular/hemostatic entities as primary manifestations of SARS-CoV-2 infection: Results of the UMC-19-S2.
    Int J Cardiol. 2021;330:268-272.
    PubMed    
    
    
    
19. SHIN SY, Park JW
    Is the Left Atrial Appendage (LAA) anatomical shape really meaningless measure for stroke risk assessment?
    Int J Cardiol. 2021;330:80-81.
    PubMed    
    
    
    April 2021
20. LANGER A, Healey JS, Quinn FR, Honos G, et al
    Detection of atrial fibrillation in asymptomatic at-risk individuals.
    Int J Cardiol. 2021 Apr 28. pii: S0167-5273(21)00737.
    PubMed     Abstract available
    
    
    
21. ELGENDY IY, Mansoor H, Pepine CJ
    Reproductive lifespan and incident stroke risk among post-menopausal women: Is it time for sex-specific risk prediction tools?
    Int J Cardiol. 2021;328:218-219.
    PubMed    
    
    
    
22. MISHRA SR, Waller M, Chung HF, Mishra GD, et al
    Association of the length of oestrogen exposure with risk of incident stroke in postmenopausal women: Insights from a 20-year prospective study.
    Int J Cardiol. 2021;328:206-214.
    PubMed     Abstract available
    
    
    March 2021
23. GAWALKO M, Dobrev D
    Oral anticoagulation and therapy of atrial flutter: discontinuation of anticoagulation revisited.
    Int J Cardiol. 2021 Mar 17. pii: S0167-5273(21)00479.
    PubMed    
    
    
    
24. STRAW S, Witte KK
    Closing the loop: Delivering personalised care for patients with cryptogenic stroke.
    Int J Cardiol. 2021;327:100-101.
    PubMed    
    
    
    
25. KRISHNAPPA D, Wang W, Rooney MR, Norby FL, et al
    Life's Simple 7 cardiovascular health score and premature atrial contractions: The atherosclerosis risk in communities (ARIC) study.
    Int J Cardiol. 2021 Mar 3. pii: S0167-5273(21)00394.
    PubMed     Abstract available
    
    
    
26. DE HEIDE J, de Wit A, Bhagwandien RE, Assaf A, et al
    Efficacy and safety of direct oral anticoagulants in patients undergoing elective electrical cardioversion: A real-world patient population.
    Int J Cardiol. 2021;326:98-102.
    PubMed     Abstract available
    
    
    February 2021
27. GIEHM-REESE M, Johansen MN, Kronborg MB, Jensen HK, et al
    Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study.
    Int J Cardiol. 2021 Feb 27. pii: S0167-5273(21)00366.
    PubMed     Abstract available
    
    
    
28. KOZIEL M, Mihajlovic M, Nedeljkovic M, Pavlovic N, et al
    Quality indicators in the management of atrial fibrillation: the BALKAN-AF survey.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00294.
    PubMed     Abstract available
    
    
    
29. COWAN LT, Buck B, Schwind JS, Lutsey PL, et al
    Triggering of cardiovascular disease by infection type: The Atherosclerosis Risk in Communities study (ARIC).
    Int J Cardiol. 2021;325:155-160.
    PubMed     Abstract available
    
    
    
30. LEGENDRE A, Moatemri F, Kovalska O, Balice-Pasquinelli M, et al
    Responses to exercise training in patients with heart failure. Analysis by oxygen transport steps.
    Int J Cardiol. 2021 Feb 8. pii: S0167-5273(21)00255.
    PubMed     Abstract available
    
    
    January 2021
31. HARIHARAN P, Giordano N, Muzikansky A, Kabrhel C, et al
    Clinical factors associated with massive pulmonary embolism and PE-related adverse clinical events.
    Int J Cardiol. 2021 Jan 31. pii: S0167-5273(21)00139.
    PubMed     Abstract available
    
    
    
32. KALARIA SN, Zhu H, Liu Q, Florian J, et al
    Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00106.
    PubMed     Abstract available
    
    
    
33. DUDZINSKA-SZCZERBA K, Michalowska I, Piotrowski R, Sikorska A, et al
    Assessment of the left atrial appendage morphology in patients after ischemic stroke - The ASSAM study.
    Int J Cardiol. 2021 Jan 29. pii: S0167-5273(21)00080.
    PubMed     Abstract available
    
    
    
34. ZWEIKER D, Manninger M, Sieghartsleitner R, Ebner J, et al
    No antiarrhythmic effect of direct oral anticoagulants versus vitamin K antagonists in paroxysmal atrial fibrillation patients undergoing catheter ablation.
    Int J Cardiol. 2021 Jan 25. pii: S0167-5273(21)00082.
    PubMed     Abstract available
    
    
    
35. DE ROQUETAILLADE C, Chousterman BG, Tomasoni D, Zeitouni M, et al
    Unusual arterial thrombotic events in Covid-19 patients.
    Int J Cardiol. 2021;323:281-284.
    PubMed     Abstract available
    
    
    
36. HWANG J, Lee SR, Park HS, Lee YS, et al
    Adherence to dabigatran and the influence of dabigatran-induced gastrointestinal discomfort in the real-world practice.
    Int J Cardiol. 2021;323:77-82.
    PubMed     Abstract available
    
    
    
37. GU K, Mahtta D, Kaneria A, Sharedalal P, et al
    Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR(R) PINNACLE Registry.
    Int J Cardiol. 2021 Jan 4. pii: S0167-5273(20)34312.
    PubMed     Abstract available
    
    
    
38. SCOGNAMIGLIO G, Fusco F, Hankel TC, Bouma BJ, et al
    Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
    Int J Cardiol. 2021;322:129-134.
    PubMed     Abstract available
    
    
    December 2020
39. FEMIA G, Zhu D, Choudhary P, Ross SB, et al
    Long term clinical outcomes associated with CMR quantified isolated left ventricular non-compaction in adults.
    Int J Cardiol. 2020 Dec 10. pii: S0167-5273(20)34265.
    PubMed     Abstract available
    
    
    
40. LENG WX, Yang JG, Li XD, Jiang WY, et al
    Impact of the shift to a fibrinolysis-first strategy on care and outcomes of patients with ST-segment-elevation myocardial infarction during the COVID-19 pandemic-The experience from the largest cardiovascular-specific centre in China.
    Int J Cardiol. 2020 Dec 8. pii: S0167-5273(20)34245.
    PubMed     Abstract available
    
    
    
41. CAPIAU A, De Backer T, Grymonprez M, Lahousse L, et al
    Appropriateness of direct oral anticoagulant dosing in patients with atrial fibrillation according to the drug labelling and EHRA Practical Guide.
    Int J Cardiol. 2020 Dec 3. pii: S0167-5273(20)34231.
    PubMed     Abstract available
    
    
    November 2020
42. KOBO O, Contractor T, Mohamed MO, Parwani P, et al
    Impact of pre-existent vascular and poly-vascular disease on acute myocardial infarction management and outcomes: An analysis of 2 million patients from the National Inpatient Sample.
    Int J Cardiol. 2020 Nov 30. pii: S0167-5273(20)34220.
    PubMed     Abstract available
    
    
    
43. CASU G, D'Angelo G, Ugo F, Ronco F, et al
    Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.
    Int J Cardiol. 2020 Nov 24. pii: S0167-5273(20)34168.
    PubMed     Abstract available
    
    
    
44. DOMINGUEZ-ERQUICIA P, Raposeiras-Roubin S, Abbu-Assi E, Cespon-Fernandez M, et al
    Incidence, predictors of bleeding and prognosis of bleeding in anticoagulated nonagenarian patients with atrial fibrillation.
    Int J Cardiol. 2020 Nov 18. pii: S0167-5273(20)34146.
    PubMed     Abstract available
    
    
    
45. MARKS D, Ho R, Then R, Weinstock JL, et al
    Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia occurrence.
    Int J Cardiol. 2020 Nov 10. pii: S0167-5273(20)34140.
    PubMed     Abstract available
    
    
    
46. ANDERSSON T, Aspberg S
    Age threshold for anticoagulation in patients with atrial fibrillation: A Swedish nationwide observational study.
    Int J Cardiol. 2020 Nov 2. pii: S0167-5273(20)34068.
    PubMed     Abstract available
    
    
    October 2020
47. VALLABHAJOSYULA S
    Reply to 'The potentially fatal consequences of fibrinolysis in misdiagnosed patients with aortic dissection'.
    Int J Cardiol. 2020 Oct 5. pii: S0167-5273(20)33910.
    PubMed    
    
    
    
48. PANA TA, Mohamed MO, Clark AB, Fahy E, et al
    Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure.
    Int J Cardiol. 2020 Oct 3. pii: S0167-5273(20)33906.
    PubMed     Abstract available
    
    
    
49. FENDER AC, Dobrev D
    The anticoagulation dilemma and future treatment avenues in patients with breast cancer and atrial fibrillation.
    Int J Cardiol. 2020 Oct 1. pii: S0167-5273(20)33897.
    PubMed    
    
    
    September 2020
50. PACHOLCZAK-MADEJ R, Bazan-Socha S, Zareba L, Undas A, et al
    Direct oral anticoagulants in the prevention of stroke in breast cancer patients with atrial fibrillation during adjuvant endocrine therapy: A cohort study.
    Int J Cardiol. 2020 Sep 12. pii: S0167-5273(20)33818.
    PubMed     Abstract available
    
    
    
51. JOLOBE OMP
    The potentially fatal consequences of fibrinolysis in misdiagnosed subjects with aortic dissection.
    Int J Cardiol. 2020 Sep 10. pii: S0167-5273(20)33798.
    PubMed    
    
    
    August 2020
52. CHANTRARAT T, Krittayaphong R
    Oral anticoagulation and cardiovascular outcomes in patients with atrial fibrillation and chronic kidney disease in Asian Population,Data from the COOL-AF Thailand registry.
    Int J Cardiol. 2020 Aug 20. pii: S0167-5273(20)33651.
    PubMed     Abstract available
    
    
    
53. LIU J, Wang Y, Guo W, Cheng Y, et al
    Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
    Int J Cardiol. 2020 Aug 16. pii: S0167-5273(20)33573.
    PubMed     Abstract available
    
    
    
54. VALLABHAJOSYULA S, Verghese D, Subramaniam AV, Kumar V, et al
    Management and outcomes of uncomplicated ST-segment elevation myocardial infarction patients transferred after fibrinolytic therapy.
    Int J Cardiol. 2020 Aug 15. pii: S0167-5273(20)33539.
    PubMed     Abstract available
    
    
    
55. CHANG KW, Xian Y, Zhao X, Mi X, et al
    Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.
    Int J Cardiol. 2020 Aug 14. pii: S0167-5273(20)33538.
    PubMed     Abstract available
    
    
    
56. RUTLAND J, Ayoub K, Etaee F, Ogunbayo G, et al
    CHA2DS2-VASc and readmission with new-onset atrial fibrillation, atrial flutter, or acute cerebrovascular accident.
    Int J Cardiol. 2020 Aug 13. pii: S0167-5273(20)33554.
    PubMed     Abstract available
    
    
    
57. MALAVASI VL, Zoccali C, Brandi MC, Micali G, et al
    Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study.
    Int J Cardiol. 2020 Aug 12. pii: S0167-5273(20)33555.
    PubMed     Abstract available
    
    
    
58. CARRERO JJ, Trevisan M, Evans M, Svennberg E, et al
    Kidney function and the risk of heart failure in patients with new-onset atrial fibrillation.
    Int J Cardiol. 2020 Aug 5. pii: S0167-5273(20)33530.
    PubMed     Abstract available
    
    
    July 2020
59. LOPES RD, Berger SE, Di Fusco M, Kang A, et al
    A review of global health technology assessments of non-VKA oral anticoagulants in non-valvular atrial fibrillation.
    Int J Cardiol. 2020 Jul 4. pii: S0167-5273(20)33439.
    PubMed     Abstract available
    
    
    June 2020
60. HUANG J, Wu N, Xiang Y, Wu L, et al
    Prognostic value of chemokines in patients with newly diagnosed atrial fibrillation.
    Int J Cardiol. 2020 Jun 27. pii: S0167-5273(20)33408.
    PubMed     Abstract available
    
    
    
61. AKHTAR T, Fratti JDC, Mattumpuram J, Fugar S, et al
    Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience.
    Int J Cardiol. 2020 Jun 26. pii: S0167-5273(20)33410.
    PubMed     Abstract available
    
    
    
62. PATTI G, Pecen L, Manu MC, Huber K, et al
    Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies.
    Int J Cardiol. 2020 Jun 20. pii: S0167-5273(20)33388.
    PubMed     Abstract available
    
    
    
63. LAUREANTI R, Conte G, Corino VDA, Osswald S, et al
    Response to "Electrocardiographic sexual differences in patients with atrial fibrillation".
    Int J Cardiol. 2020;308:50-51.
    PubMed    
    
    
    May 2020
64. LEIVO J, Anttonen E, Jolly SS, Dzavik V, et al
    The high-risk ECG pattern of ST-elevation myocardial infarction: A substudy of the randomized trial of primary PCI with or without routine manual thrombectomy (TOTAL trial).
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)31075.
    PubMed     Abstract available
    
    
    
65. JAUME FP, Aleix OS, Nuria RG, Jordi PR, et al
    High incidence of subclinical atrial fibrillation in patients with syncope monitored with implantable cardiac monitor.
    Int J Cardiol. 2020 May 26. pii: S0167-5273(20)32451.
    PubMed     Abstract available
    
    
    April 2020
66. PUGLIESE NR, Masi S
    Circulating interleukins, coronary artery disease, ischemic stroke and atrial fibrillation: Connecting the dots between inflammation and cardiovascular disease.
    Int J Cardiol. 2020 Apr 21. pii: S0167-5273(20)31424.
    PubMed    
    
    
    
67. GEARY L, Hasselstrom J, Carlsson AC, Schenck-Gustafsson K, et al
    An audit & feedback intervention for improved anticoagulant use in patients with atrial fibrillation in primary care.
    Int J Cardiol. 2020 Apr 12. pii: S0167-5273(20)30628.
    PubMed    
    
    
    March 2020
68. YUAN S, Lin A, He QQ, Burgess S, et al
    Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study.
    Int J Cardiol. 2020 Mar 21. pii: S0167-5273(20)30701.
    PubMed     Abstract available
    
    
    
69. CHEN L, He W, Liu F, Wang T, et al
    Stroke in pulmonary hypertension: Is it predictable or preventable?
    Int J Cardiol. 2020;303:79.
    PubMed    
    
    
    
70. ZAKERI R, Morgan JM, Phillips P, Kitt S, et al
    Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
    Int J Cardiol. 2020 Mar 3. pii: S0167-5273(19)34926.
    PubMed     Abstract available
    
    
    February 2020
71. NEDIOS S, Dobrev D
    Electrocardiographic sex-related differences in patients with atrial fibrillation: Do they allow a better risk stratification?
    Int J Cardiol. 2020 Feb 19. pii: S0167-5273(20)30218.
    PubMed    
    
    
    January 2020
72. BAE JH, Corban MT, Seo YH, Kim T, et al
    Ten-year clinical outcomes of an intermediate coronary lesion; prognosis and predictors of major adverse cardiovascular events.
    Int J Cardiol. 2020;299:26-30.
    PubMed     Abstract available
    
    
    
73. LAUREANTI R, Conte G, Corino VDA, Osswald S, et al
    Sex-related electrocardiographic differences in patients with different types of atrial fibrillation: Results from the SWISS-AF study.
    Int J Cardiol. 2020 Jan 3. pii: S0167-5273(19)34685.
    PubMed     Abstract available
    
    
    
74. MICHOU E, Gualandro D, Mueller C
    It is B-type and not brain natriuretic peptide after all.
    Int J Cardiol. 2020;298:114-115.
    PubMed    
    
    
    
75. RODRIGUEZ-CASTRO E, Hervella P, Lopez-Dequidt I, Arias-Rivas S, et al
    NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
    Int J Cardiol. 2020;298:93-97.
    PubMed     Abstract available
    
    
    December 2019
76. BAHIT MC, Granger CB, Alexander JH, Mulder H, et al
    Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
    Int J Cardiol. 2019 Dec 30. pii: S0167-5273(19)34634.
    PubMed     Abstract available
    
    
    
77. STEWART LK, Beam DM, Casciani T, Cameron SJ, et al
    Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
    Int J Cardiol. 2019 Dec 26. pii: S0167-5273(19)30431.
    PubMed     Abstract available
    
    
    
78. HU QW, Bao TZ, Yang HR
    NT-pro-BNP: A promising predictor of stroke risk after transient ischemic attack.
    Int J Cardiol. 2019;297:142.
    PubMed    
    
    
    
79. SHAH TG, Sutaria JM, Vyas MV
    The association between pulmonary hypertension and stroke: a systematic review and meta-analysis.
    Int J Cardiol. 2019 Dec 12. pii: S0167-5273(19)35735.
    PubMed    
    
    
    November 2019
80. SPOSATO LA, Spence JD
    Patent foramen ovale in patients with atrial fibrillation.
    Int J Cardiol. 2019 Nov 22. pii: S0167-5273(19)35608.
    PubMed    
    
    
    
81. NAGAI M, Dote K, Kato M
    Left atrial fibrosis after ischemic stroke: How the insular cortex-ganglionated plexi axis interacts?
    Int J Cardiol. 2019;294:16.
    PubMed    
    
    
    
82. JAREMEK VM, Whitehead S, Sposato LA
    Lateralization of the control of cardiovascular autonomic function and left atrial injury after selective right and left insular stroke.
    Int J Cardiol. 2019;294:15.
    PubMed    
    
    
    October 2019
83. LUCIJANIC M, Jurin I, Jurin H, Lucijanic T, et al
    Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.
    Int J Cardiol. 2019 Oct 30. pii: S0167-5273(19)34260.
    PubMed     Abstract available
    
    
    
84. LI HL, Wu S, Chan YC, Cheng SW, et al
    Early and mid-term mortality and morbidity of contemporary international endovascular treatment for type B aortic dissection - A systematic review and meta-analysis.
    Int J Cardiol. 2019 Oct 24. pii: S0167-5273(19)31112.
    PubMed     Abstract available
    
    
    July 2019
85. SHAH TG, Sutaria JM, Vyas MV
    The association between pulmonary hypertension and stroke: A systematic review and meta-analysis.
    Int J Cardiol. 2019 Jul 31. pii: S0167-5273(19)31075.
    PubMed     Abstract available
    
    
    
86. BORIANI G, Healey JS, Schnabel RB, Lopes RD, et al
    Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group.
    Int J Cardiol. 2019 Jul 11. pii: S0167-5273(19)32817.
    PubMed     Abstract available
    
    
    June 2019
87. SATOH K, Shimokawa H
    Sirtuin 5 promotes ischemia/reperfusion-induced blood-brain barrier damage after stroke.
    Int J Cardiol. 2019;284:77-78.
    PubMed    
    
    
    May 2019
88. BOTTO GL, Brasca FMA
    Stroke risk assessment in atrial fibrillation: Beyond atrial rhythm.
    Int J Cardiol. 2019 May 24. pii: S0167-5273(19)32435.
    PubMed    
    
    
    
89. STEPIEN K, Nowak K, Wypasek E, Zalewski J, et al
    High prevalence of inherited thrombophilia and antiphospholipid syndrome in myocardial infarction with non-obstructive coronary arteries: Comparison with cryptogenic stroke.
    Int J Cardiol. 2019 May 18. pii: S0167-5273(19)30879.
    PubMed     Abstract available
    
    
    April 2019
90. LEONARD JR, Di Franco A, Gaudino M
    Authors' reply to Preoperative CT scan for Postoperative Stroke Prediction in Minimally Invasive Mitral Valve Surgery: Statistical Concern for Clinical Factors in Regression analyses.
    Int J Cardiol. 2019;281:157.
    PubMed    
    
    
    
91. LOU B, Zhou C
    Preoperative CT scan for postoperative stroke prediction in minimally invasive mitral valve surgery: Statistical concern for clinical factors in regression analyses.
    Int J Cardiol. 2019;281:156.
    PubMed    
    
    
    
92. SORIGUE M, Sarrate E, Miljkovic MD
    Anticoagulation for atrial fibrillation in patients with active cancer.
    Int J Cardiol. 2019;280:98.
    PubMed    
    
    
    March 2019
93. MOSCARELLI M
    CT scan in minimally invasive surgery: A call to safety.
    Int J Cardiol. 2019;278:307-308.
    PubMed    
    
    
    
94. REIFFEL JA
    Apples will never be oranges, but when you go fishing you may get a bite.
    Int J Cardiol. 2019;278:155-156.
    PubMed    
    
    
    February 2019
95. DE GREGORIO MA, Guirola JA, Kuo WT, Serrano C, et al
    Catheter-directed aspiration thrombectomy and low-dose thrombolysis for patients with acute unstable pulmonary embolism: Prospective outcomes from a PE registry.
    Int J Cardiol. 2019 Feb 28. pii: S0167-5273(18)36761.
    PubMed     Abstract available
    
    
    
96. CORDERO A, Rodriguez-Manero M, Garcia-Acuna JM, Bertomeu-Gonzalez V, et al
    Incidence and predictors of stroke in patients discharged with the diagnosis of acute coronary syndrome.
    Int J Cardiol. 2019;276:20-25.
    PubMed     Abstract available
    
    
    January 2019
97. GIUSTOZZI M, Vedovati MC, Verso M, Scrucca L, et al
    Patients aged 90years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study.
    Int J Cardiol. 2019 Jan 25. pii: S0167-5273(18)37162.
    PubMed     Abstract available
    
    
    
98. DANNENBERG L, Mourikis P, Naguib D, Zako S, et al
    Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation.
    Int J Cardiol. 2019;275:95-100.
    PubMed     Abstract available
    
    
    
99. GOROG DA
    Lowering the risk of stroke prevention: Managing bleeding complications.
    Int J Cardiol. 2019;274:351-352.
    PubMed    
    
    
    December 2018
100. CRISTINA V
     Oxidative stress and cardiovascular risk prediction: The long way towards a "radical" perspective.
     Int J Cardiol. 2018;273:252-253.
     PubMed    
     
     
     
101. PICKETT CA, Villines TC, Resar JR, Hulten EA, et al
     Cost effectiveness and clinical efficacy of patent foramen ovale closure as compared to medical therapy in cryptogenic stroke patients: A detailed cost analysis and meta-analysis of randomized controlled trials.
     Int J Cardiol. 2018;273:74-79.
     PubMed     Abstract available
     
     
     
102. ATHANASSOPOULOS GD, Armenis I
     Secondary stroke prevention in atrial fibrillation: Still lacking pace?
     Int J Cardiol. 2018 Dec 15. pii: S0167-5273(18)36306.
     PubMed    
     
     
     
103. LEONARD JR, Henry M, Rahouma M, Khan FM, et al
     Systematic preoperative CT scan is associated with reduced risk of stroke in minimally invasive mitral valve surgery: A meta-analysis.
     Int J Cardiol. 2018 Dec 12. pii: S0167-5273(18)35962.
     PubMed     Abstract available
     
     
     
104. SPARTALIS M, Tzatzaki E, Paschou SA, Spartalis E, et al
     Type 1 diabetes is associated with increased risk of atrial fibrillation.
     Int J Cardiol. 2018 Dec 4. pii: S0167-5273(18)34989.
     PubMed    
     
     
     
105. EHRLICH JR, Look C, Kostev K, Israel CW, et al
     Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany.
     Int J Cardiol. 2018 Dec 1. pii: S0167-5273(18)34728.
     PubMed     Abstract available
     
     
     November 2018
106. FERREIRO JL, Gomez-Hospital JA
     Antithrombotic therapy after acute coronary syndromes in patients with atrial fibrillation: Shouldn't we pay more attention to the risk of ischemic and thromboembolic events?
     Int J Cardiol. 2018 Nov 29. pii: S0167-5273(18)36183.
     PubMed    
     
     
     
107. WANG H, Wang S, Sun Y
     Could red blood cell distribution width predict high CHADS2 and CHADS2-VASC score in adults with atrial fibrillation? A focus on the general population.
     Int J Cardiol. 2018;271:345.
     PubMed    
     
     
     
108. LI J, Wang X, Sun M, Yan G, et al
     "Rebound" hypercoagulability after interruption of anticoagulation in patients with atrial fibrillation.
     Int J Cardiol. 2018;271:119.
     PubMed    
     
     
     
109. STRENG KW, Nauta JF, Hillege HL, Anker SD, et al
     Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction.
     Int J Cardiol. 2018;271:132-139.
     PubMed     Abstract available
     
     
     
110. POLZIN A, Dannenberg L, Wolff G, Zeus T, et al
     Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer?
     Int J Cardiol. 2018;270:82.
     PubMed    
     
     
     October 2018
111. SLUYTER JD, Camargo CA Jr, Lowe A, Scragg RKR, et al
     Pulse rate variability predicts atrial fibrillation and cerebrovascular events in a large, population-based cohort.
     Int J Cardiol. 2018 Oct 10. pii: S0167-5273(18)34448.
     PubMed     Abstract available
     
     
     
112. CALDEIRA D
     Non-vitamin K antagonist oral anticoagulants (NOACs) in cardioversions: The past, the present and the future.
     Int J Cardiol. 2018;268:149-150.
     PubMed    
     
     
     September 2018
113. GUTTMANN OP
     Atrial fibrillation and thromboembolism in hypertrophic cardiomyopathy - An underestimated risk.
     Int J Cardiol. 2018 Sep 19. pii: S0167-5273(18)35180.
     PubMed    
     
     
     
114. CILIBERTI G, Coiro S, Tritto I, Benedetti M, et al
     Predictors of poor clinical outcomes in patients with acute myocardial infarction and non-obstructed coronary arteries (MINOCA).
     Int J Cardiol. 2018;267:41-45.
     PubMed     Abstract available
     
     
     
115. KIM H, Senecal C, Lewis B, Prasad A, et al
     Natural history and predictors of mortality of patients with Takotsubo syndrome.
     Int J Cardiol. 2018;267:22-27.
     PubMed     Abstract available
     
     
     
116. VAN DOORN S, Rutten FH, O'Flynn CM, Oudega R, et al
     Effectiveness of CHA2DS2-VASc based decision support on stroke prevention in atrial fibrillation: A cluster randomised trial in general practice.
     Int J Cardiol. 2018 Sep 8. pii: S0167-5273(18)33685.
     PubMed     Abstract available
     
     
     
117. CHEN HL, Cai JY, Zha ML, Liu K, et al
     Does CHA2DS2-VASc score have the discrimination and calibration power in predicting renal function decline?
     Int J Cardiol. 2018;266:161.
     PubMed    
     
     
     
118. WANG S, Su Z, Zhang Y
     The true prevalence of inappropriate anticoagulation therapy in Chinese patients with a CHA2DS2-VASc score of 0.
     Int J Cardiol. 2018;266:159.
     PubMed    
     
     
     
119. KADHIM K, Lau DH, Linz D, Sanders P, et al
     Improved survival and reduced stroke risk in patients with atrial fibrillation: Is catheter ablation winning the rhythm-control race?
     Int J Cardiol. 2018;266:153-154.
     PubMed    
     
     
     
120. PASCERI V, Pelliccia F, Bressi E, Mantione L, et al
     Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials.
     Int J Cardiol. 2018;266:75-80.
     PubMed     Abstract available
     
     
     
121. BARRA S, Baran J, Narayanan K, Boveda S, et al
     Association of catheter ablation for atrial fibrillation with mortality and stroke: A systematic review and meta-analysis.
     Int J Cardiol. 2018;266:136-142.
     PubMed     Abstract available
     
     
     
122. LI YG, Miyazawa K, Wolff A, Zubaid M, et al
     One-year risks of stroke and mortality in patients with atrial fibrillation from different clinical settings: The Gulf SAFE registry and Darlington AF registry.
     Int J Cardiol. 2018 Sep 1. pii: S0167-5273(18)34355.
     PubMed     Abstract available
     
     
     August 2018
123. HIGASHI Y
     Does renal function have incremental predictive value of stroke in atrial fibrillation?
     Int J Cardiol. 2018 Aug 29. pii: S0167-5273(18)34620.
     PubMed    
     
     
     
124. CHOI YJ, Choi EK, Han KD, Jung JH, et al
     Temporal trends of the prevalence and incidence of atrial fibrillation and stroke among Asian patients with hypertrophic cardiomyopathy: A nationwide population-based study.
     Int J Cardiol. 2018 Aug 11. pii: S0167-5273(18)33740.
     PubMed     Abstract available
     
     
     
125. MULDER BA, Geelhoed B, van der Harst P, Spronk HM, et al
     Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study.
     Int J Cardiol. 2018 Aug 10. pii: S0167-5273(18)34407.
     PubMed    
     
     
     
126. XUAN Y, Gao X, Holleczek B, Brenner H, et al
     Prediction of myocardial infarction, stroke and cardiovascular mortality with urinary biomarkers of oxidative stress: Results from a large cohort study.
     Int J Cardiol. 2018 Aug 3. pii: S0167-5273(18)33360.
     PubMed     Abstract available
     
     
     
127. FISCHER Q, Georges JL, Le Feuvre C, Sharma A, et al
     Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: "OLTAT registry".
     Int J Cardiol. 2018;264:64-69.
     PubMed     Abstract available
     
     
     
128. RUBBOLI A
     Oral anticoagulation alone for concomitant stable coronary artery disease and atrial fibrillation: A definitive strategy?
     Int J Cardiol. 2018;264:95-96.
     PubMed    
     
     
     
129. MARIN F, Roldan V
     Oral anticoagulation and comorbidities; too many details for clinical practice?
     Int J Cardiol. 2018;264:93-94.
     PubMed    
     
     
     
130. FRIBERG L
     Safety of apixaban in combination with dronedarone in patients with atrial fibrillation.
     Int J Cardiol. 2018;264:85-90.
     PubMed     Abstract available
     
     
     
131. PASTORI D, Lip GYH, Farcomeni A, Del Sole F, et al
     Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants.
     Int J Cardiol. 2018;264:58-63.
     PubMed     Abstract available
     
     
     
132. PICHLER G, Amigo N, Tellez-Plaza M, Pardo-Cea MA, et al
     LDL particle size and composition and incident cardiovascular disease in a South-European population: The Hortega-Liposcale Follow-up Study.
     Int J Cardiol. 2018;264:172-178.
     PubMed     Abstract available
     
     
     July 2018
133. VEDOVATI MC, Giustozzi M, Verdecchia P, Pierpaoli L, et al
     Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study.
     Int J Cardiol. 2018 Jul 29. pii: S0167-5273(18)32719.
     PubMed     Abstract available
     
     
     
134. MCALISTER FA, Wiebe N, Ronksley PE, Healey JS, et al
     Although non-stroke outcomes are more common, stroke risk scores can be used for prediction in patients with atrial fibrillation.
     Int J Cardiol. 2018 Jul 27. pii: S0167-5273(18)33059.
     PubMed     Abstract available
     
     
     
135. RIVA L, Ageno W, Di Pasquale G, Agnelli G, et al
     Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism.
     Int J Cardiol. 2018 Jul 26. pii: S0167-5273(18)32356.
     PubMed     Abstract available
     
     
     
136. MIYAZAWA K, Li YG, Rashed WA, Al Mahmeed W, et al
     Secondary stroke prevention and guideline adherent antithrombotic treatment in patients with atrial fibrillation: Insights from the Gulf Survey of atrial fibrillation events (Gulf SAFE).
     Int J Cardiol. 2018 Jul 24. pii: S0167-5273(18)33607.
     PubMed     Abstract available
     
     
     
137. KOBAYASHI N, Hata N, Tsurumi M, Shibata Y, et al
     Relation of coronary culprit lesion morphology determined by optical coherence tomography and cardiac outcomes to preinfarction angina in patients with acute myocardial infarction.
     Int J Cardiol. 2018 Jul 18. pii: S0167-5273(18)32180.
     PubMed     Abstract available
     
     
     
138. MARZONA I, Proietti M, Farcomeni A, Romiti GF, et al
     Sex differences in stroke and major adverse clinical events in patients with atrial fibrillation: A systematic review and meta-analysis of 993,600 patients.
     Int J Cardiol. 2018 Jul 9. pii: S0167-5273(18)33433.
     PubMed     Abstract available
     
     
     
139. BURLACU A, Covic A
     'Some doors are better left closed': Using LAA occluders as an alternative to warfarin in very high-risk dialysed patients with atrial fibrillation.
     Int J Cardiol. 2018;262:43-44.
     PubMed    
     
     
     June 2018
140. WENG CJ, Li CH, Liao YC, Lin CC, et al
     Rhythm control better prevents stroke and mortality than rate control strategies in patients with atrial fibrillation - A nationwide cohort study.
     Int J Cardiol. 2018 Jun 26. pii: S0167-5273(18)33463.
     PubMed     Abstract available
     
     
     
141. AYABE K, Goto S
     High rate of death in patients with atrial fibrillation -Results from EORP-AF Pilot General Registry.
     Int J Cardiol. 2018 Jun 22. pii: S0167-5273(18)33076.
     PubMed    
     
     
     
142. ANDERSSON NW, Svanstrom H, Lund M, Pasternak B, et al
     Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation.
     Int J Cardiol. 2018 Jun 19. pii: S0167-5273(17)35612.
     PubMed     Abstract available
     
     
     
143. SPOSATO LA, Lopes RD
     Disentangling the risk of atrial fibrillation detected after ischemic stroke (AFDAS): A real challenge in clinical practice.
     Int J Cardiol. 2018;261:99-100.
     PubMed    
     
     
     
144. HSIEH CY, Lee CH, Wu DP, Sung SF, et al
     Characteristics and outcomes of ischemic stroke in patients with known atrial fibrillation or atrial fibrillation diagnosed after stroke.
     Int J Cardiol. 2018;261:68-72.
     PubMed     Abstract available
     
     
     
145. FENDER AC, Dobrev D
     Switching off the jitters: Dabigatran as a candidate approach to halt atrial fibrillation?
     Int J Cardiol. 2018 Jun 13. pii: S0167-5273(18)33661.
     PubMed    
     
     
     
146. WANG X, Fu Q, Song F, Li W, et al
     Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
     Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
     PubMed     Abstract available
     
     
     
147. PARASKEVAS KI, Naylor AR
     Carotid artery stenosis at the time of coronary artery bypass grafting is a risk factor but not a cause for peri-operative stroke.
     Int J Cardiol. 2018;260:23.
     PubMed    
     
     
     May 2018
148. VISZLAYOVA D, Brozman M, Langova K, Herzig R, et al
     Sonolysis in risk reduction of symptomatic and silent brain infarctions during coronary stenting (SONOREDUCE): Randomized, controlled trial.
     Int J Cardiol. 2018 May 26. pii: S0167-5273(18)30634.
     PubMed     Abstract available
     
     
     
149. FENDER AC, Dobrev D
     The not-so-sweet problem of hearts aflutter: Dissecting stroke risk in atrial fibrillation with concomitant diabetes.
     Int J Cardiol. 2018 May 19. pii: S0167-5273(18)33126.
     PubMed    
     
     
     
150. SCHOOLING CM, Luo S, Au Yeung SL, Thompson DJ, et al
     Genetic predictors of testosterone and their associations with cardiovascular disease and risk factors: A Mendelian randomization investigation.
     Int J Cardiol. 2018 May 18. pii: S0167-5273(17)36101.
     PubMed     Abstract available
     
     
     
151. ESCOBAR-ROBLEDO LA, Bayes-de-Luna A, Lupon J, Baranchuk A, et al
     Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.
     Int J Cardiol. 2018 May 18. pii: S0167-5273(18)31019.
     PubMed     Abstract available
     
     
     April 2018
152. SHENG X, Ding S, Ge H, Sun Y, et al
     Intracoronary infusion of alprostadil and nitroglycerin with targeted perfusion microcatheter in STEMI patients with coronary slow flow phenomenon.
     Int J Cardiol. 2018 Apr 25. pii: S0167-5273(17)37021.
     PubMed     Abstract available
     
     
     
153. LUO J, Li H, Qin X, Liu B, et al
     Increased risk of ischemic stroke associated with new-onset atrial fibrillation complicating acute coronary syndrome: A systematic review and meta-analysis.
     Int J Cardiol. 2018 Apr 23. pii: S0167-5273(17)37900.
     PubMed     Abstract available
     
     
     
154. SILLER-MATULA JM, Pecen L, Patti G, Lucerna M, et al
     Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.
     Int J Cardiol. 2018 Apr 22. pii: S0167-5273(17)37365.
     PubMed     Abstract available
     
     
     
155. BAI J, Shen D, Wang B, Han Q, et al
     Could the CHA2DS2-VASc schema help stratify risk of ischemic stroke for individual patients with congestive heart failure?
     Int J Cardiol. 2018;257:226.
     PubMed    
     
     
     
156. JIA X, Levine GN, Birnbaum Y
     The CHA2DS2-VASc score: Not as simple as it seems.
     Int J Cardiol. 2018;257:92-96.
     PubMed     Abstract available
     
     
     
157. BARNETT AS, Cyr DD, Goodman SG, Levitan BS, et al
     Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF.
     Int J Cardiol. 2018;257:78-83.
     PubMed     Abstract available
     
     
     
158. LAMBIASE PD
     AF stroke risk stratification-can we do better?
     Int J Cardiol. 2018;257:108-109.
     PubMed    
     
     
     
159. MIRZADA N, Ladenvall P, Hansson PO, Eriksson P, et al
     Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample.
     Int J Cardiol. 2018;257:46-49.
     PubMed     Abstract available
     
     
     
160. LI B, Sun C, Qin F, Liu N, et al
     Could direct oral anticoagulants be an alternative to vitamin K antagonists in patients with hypertrophic cardiomyopathy and atrial fibrillation?
     Int J Cardiol. 2018;256:39.
     PubMed    
     
     
     March 2018
161. PICCOLO R, Franzone A, Siontis GCM, Stortecky S, et al
     Patent foramen ovale closure vs. medical therapy for recurrent stroke prevention: Evolution of treatment effect during follow-up.
     Int J Cardiol. 2018;255:29-31.
     PubMed     Abstract available
     
     
     
162. BISSON A, Bodin A, Clementy N, Bernard A, et al
     Stroke, thromboembolism and bleeding in patients with atrial fibrillation according to the EHRA valvular heart disease classification.
     Int J Cardiol. 2018 Mar 7. pii: S0167-5273(18)30084.
     PubMed     Abstract available
     
     
     
163. MUJOVIC N, Potpara TS
     Optimizing bleeding risk assessment in patients with atrial fibrillation: To score or not to score?
     Int J Cardiol. 2018;254:164-166.
     PubMed    
     
     
     February 2018
164. GOETTE A
     Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"?
     Int J Cardiol. 2018;253:82-83.
     PubMed    
     
     
     
165. SHIMOKAWA H, Yamashita T, Uchiyama S, Kitazono T, et al
     The EXPAND study: Efficacy and safety of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
     Int J Cardiol. 2018 Feb 3. pii: S0167-5273(18)30592.
     PubMed     Abstract available
     
     
     
166. FAUCHIER L, Bisson A, Genet T
     Antiplatelet therapy, vitamin K antagonist and low time in therapeutic range in patients with atrial fibrillation: Highway to bleed.
     Int J Cardiol. 2018;252:110-111.
     PubMed    
     
     
     January 2018
167. CAVALLARI I, Ruff CT, Nordio F, Deenadayalu N, et al
     Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
     Int J Cardiol. 2018 Jan 26. pii: S0167-5273(17)35262.
     PubMed     Abstract available
     
     
     
168. JOLOBE OMP
     Proposed rationale for anticoagulants in nonvalvular atrial fibrillation with zero CHA2DS2-Vasc score.
     Int J Cardiol. 2018 Jan 21. pii: S0167-5273(17)36194.
     PubMed    
     
     
     
169. QIN F, Liu N, Liu C, Bai F, et al
     Could excessive atrial ectopic activity be an independent risk factor for ischemic stroke?
     Int J Cardiol. 2018;251:53.
     PubMed    
     
     
     
170. BAI R
     Percutaneous left atrial appendage closure versus oral anticoagulant: A bird in the hand is worth two in the bush?
     Int J Cardiol. 2018;251:51-52.
     PubMed    
     
     
     
171. FERLINI M, Rossini R
     Left atrial appendage closure: Six reasons why I wouldn't choose a percutaneous closure for my appendage.
     Int J Cardiol. 2018;251:42-44.
     PubMed     Abstract available
     
     
     
172. WAKABAYASHI K, Ikeda N, Kajimoto K, Minami Y, et al
     Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.
     Int J Cardiol. 2018;250:164-170.
     PubMed     Abstract available
     
     
     December 2017
173. WONG CX
     Atrial fibrillation, hip fracture, and oral anticoagulation therapy.
     Int J Cardiol. 2017;249:260.
     PubMed    
     
     
     
174. CERIT L
     Atrial fibrillation, hip fracture, and oral anticoagulant therapy.
     Int J Cardiol. 2017;249:259.
     PubMed    
     
     
     
175. GOETTE A
     Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF?
     Int J Cardiol. 2017;249:247-248.
     PubMed    
     
     
     November 2017
176. MAKOWSKI M, Baj Z
     New biomarkers in risk stratification in patients with atrial fibrillation.
     Int J Cardiol. 2017;247:19.
     PubMed    
     
     
     
177. BARKAS F, Elisaf M, Liberopoulos E
     Low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores for the prediction of new-onset atrial fibrillation.
     Int J Cardiol. 2017;247:18.
     PubMed    
     
     
     
178. QIN F, Zhao Y, He B, Liu Q, et al
     Could low high-density lipoprotein cholesterol levels improve the performance of the CHADS2 and CHA2DS2-VASc scores in predicting new atrial fibrillation?
     Int J Cardiol. 2017;247:17.
     PubMed    
     
     
     
179. EL-BATTRAWY I, Borggrefe M, Akin I
     Atrial fibrillation as a risk factor for worse outcome in acute coronary syndrome.
     Int J Cardiol. 2017;246:53.
     PubMed    
     
     
     October 2017
180. WIYEH AB, Ochodo EA, Wiysonge CS, Kakia A, et al
     A systematic review of the efficacy and safety of intrapericardial fibrinolysis in patients with pericardial effusion.
     Int J Cardiol. 2017 Oct 26. pii: S0167-5273(17)35919.
     PubMed     Abstract available
     
     
     
181. PAGOLA J, Juega J, Francisco-Pascual J, Moya A, et al
     Yield of atrial fibrillation detection with Textile Wearable Holter from the acute phase of stroke: Pilot study of Crypto-AF registry.
     Int J Cardiol. 2017 Oct 22. pii: S0167-5273(17)33896.
     PubMed     Abstract available
     
     
     
182. TSE G, Lip GYH, Liu T
     The CHADS2 and CHA2DS2-VASc scores for predicting healthcare utilization and outcomes: Observations on the Appropriate Use and Misuse of Risk scores.
     Int J Cardiol. 2017;245:181-182.
     PubMed    
     
     
     
183. WANG S, Li J, Yan G, Zhang Y, et al
     New biomarkers' improvement of thrombogenesis risk stratification in patients with atrial fibrillation and CHA2DS2-VASc Score 1.
     Int J Cardiol. 2017;244:296.
     PubMed    
     
     
     September 2017
184. DENAS G, Gennaro N, Ferroni E, Fedeli U, et al
     Effectiveness and safety of oral anticoagulation with non-vitamin K antagonists compared to well-managed vitamin K antagonists in naive patients with non-valvular atrial fibrillation: Propensity score matched cohort study.
     Int J Cardiol. 2017 Sep 18. pii: S0167-5273(17)32377.
     PubMed     Abstract available
     
     
     
185. SAMBOLA A, Ruiz-Meana M, Barba I, Del Blanco BG, et al
     Glycative and oxidative stress are associated with altered thrombus composition in diabetic patients with ST-elevation myocardial infarction.
     Int J Cardiol. 2017;243:9-14.
     PubMed     Abstract available
     
     
     
186. TOCCI G, Presta V
     Increased arterial stiffness and haemorrhagic transformation in ischaemic stroke after thrombolysis: A new marker of risk for cerebrovascular events and complications.
     Int J Cardiol. 2017;243:471-472.
     PubMed    
     
     
     
187. ACAMPA M, Camarri S, Lazzerini PE, Guideri F, et al
     Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis.
     Int J Cardiol. 2017;243:466-470.
     PubMed     Abstract available
     
     
     
188. AYUBI E, Safiri S
     Comments on CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation.
     Int J Cardiol. 2017;242:9.
     PubMed    
     
     
     
189. HU WS, Lin CL
     Reply: CHA2DS2-VASc score in the prediction of ischemic bowel disease among patients with atrial fibrillation: Insights from a nationwide cohort.
     Int J Cardiol. 2017;242:10.
     PubMed    
     
     
     August 2017
190. GLOEKLER S, Saw J, Koskinas KC, Kleinecke C, et al
     Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
     Int J Cardiol. 2017 Aug 26. pii: S0167-5273(17)33620.
     PubMed     Abstract available
     
     
     July 2017
191. KANG SH, Kim J, Park JJ, Oh IY, et al
     Risk of stroke in congestive heart failure with and without atrial fibrillation.
     Int J Cardiol. 2017 Jul 20. pii: S0167-5273(17)30701.
     PubMed     Abstract available
     
     
     
192. ROSSELLO X, Huo Y, Pocock S, de Werf FV, et al
     Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality.
     Int J Cardiol. 2017 Jul 15. pii: S0167-5273(17)32845.
     PubMed     Abstract available
     
     
     
193. CERIT L
     Dual risk stratification for dual antiplatelet therapy: SYNTAX and CHA2DS2-VASc score.
     Int J Cardiol. 2017;239:22.
     PubMed    
     
     
     
194. NOSEWORTHY PA, Yao X, Gersh BJ, Hargraves I, et al
     Long-term stroke and bleeding risk in patients with atrial fibrillation treated with oral anticoagulants in contemporary practice: Providing evidence for shared decision-making.
     Int J Cardiol. 2017 Jul 14. pii: S0167-5273(17)32969.
     PubMed     Abstract available
     
     
     June 2017
195. LAVI S, Iqbal J, Cairns JA, Cantor WJ, et al
     Bare metal versus drug eluting stents for ST-segment elevation myocardial infarction in the TOTAL trial.
     Int J Cardiol. 2017 Jun 29. pii: S0167-5273(17)33508.
     PubMed     Abstract available
     
     
     
196. VIDALE S, Arnaboldi M, Bosio V, Corrado G, et al
     Short-term air pollution exposure and cardiovascular events: A 10-year study in the urban area of Como, Italy.
     Int J Cardiol. 2017 Jun 15. pii: S0167-5273(17)31683.
     PubMed     Abstract available
     
     
     
197. CAPPELLARI M, Bovi P
     Direct oral anticoagulants in patients with cervical artery dissection and cerebral venous thrombosis. A case series and review of the literature.
     Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32629.
     PubMed     Abstract available
     
     
     
198. HOLDA MK, Koziej M, Wszolek K, Pawlik W, et al
     Left atrial accessory appendages, diverticula, and left-sided septal pouch in multi-slice computed tomography. Association with atrial fibrillation and cerebrovascular accidents.
     Int J Cardiol. 2017 Jun 13. pii: S0167-5273(17)32424.
     PubMed     Abstract available
     
     
     
199. ZIEGLER PD, Rogers JD, Ferreira SW, Nichols AJ, et al
     Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population.
     Int J Cardiol. 2017 Jun 10. pii: S0167-5273(17)32506.
     PubMed     Abstract available
     
     
     
200. CARMO J, Ferreira J, Costa F, Carmo P, et al
     Non-vitamin K antagonist oral anticoagulants compared with warfarin at different levels of INR control in atrial fibrillation: A meta-analysis of randomized trials.
     Int J Cardiol. 2017 Jun 3. pii: S0167-5273(17)31600.
     PubMed     Abstract available
     
     
     
201. ACHILLES A, Mohring A, Dannenberg L, Piayda K, et al
     Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.
     Int J Cardiol. 2017;236:76-81.
     PubMed     Abstract available
     
     
     
202. MEFFORD M, Safford MM, Muntner P, Durant RW, et al
     Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic And Racial Differences in Stroke study.
     Int J Cardiol. 2017;236:462-465.
     PubMed     Abstract available
     
     
     
203. CHAIKRIANGKRAI K, Jhun HY, Palamaner Subash Shantha G, Bin Abdulhak A, et al
     Coronary artery calcium score as a predictor for incident stroke: Systematic review and meta-analysis.
     Int J Cardiol. 2017;236:473-477.
     PubMed     Abstract available
     
     
     May 2017
204. MATUSIK PT, Matusik PS, Kornacewicz-Jach Z, Malecka B, et al
     Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.
     Int J Cardiol. 2017 May 16. pii: S0167-5273(17)31785.
     PubMed     Abstract available
     
     
     
205. BECATTINI C, Franco L, Agnelli G
     Risk of death in patients with major bleedings while on treatment with oral anticoagulants.
     Int J Cardiol. 2017;235:200.
     PubMed    
     
     
     
206. ALEXOPOULOS D
     Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
     Int J Cardiol. 2017;234:131.
     PubMed    
     
     
     
207. SUZUKI M, Takanashi S
     Assessment of clinical severity in patients with infective endocarditis with cardio-embolic strokes.
     Int J Cardiol. 2017;234:140.
     PubMed    
     
     
     April 2017
208. KWOK CS, Bagur R, Rashid M, Lavi R, et al
     Aortic stenosis and non-cardiac surgery: A systematic review and meta-analysis.
     Int J Cardiol. 2017 Apr 12. pii: S0167-5273(16)34897.
     PubMed     Abstract available
     
     
     March 2017
209. SHEN L, Song L, Liu B, Li H, et al
     Effects of early age at natural menopause on coronary heart disease and stroke in Chinese women.
     Int J Cardiol. 2017 Mar 30. pii: S0167-5273(16)33287.
     PubMed     Abstract available
     
     
     
210. KAIER K, Reinecke H, Schmoor C, Frankenstein L, et al
     Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study.
     Int J Cardiol. 2017 Mar 2. pii: S0167-5273(17)31288.
     PubMed     Abstract available
     
     
     
211. KLAER J, Mahler A, Scherbakov N, Klug L, et al
     Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
     Int J Cardiol. 2017;230:241-247.
     PubMed     Abstract available
     
     
     February 2017
212. PROIETTI M, Lip GY
     Geographical differences in thromboembolic and bleeding risks in patients with non-valvular atrial fibrillation: An ancillary analysis from the SPORTIF trials.
     Int J Cardiol. 2017 Feb 27. pii: S0167-5273(17)30411.
     PubMed     Abstract available
     
     
     
213. LEE SR, Choi EK, Han KD, Cha MJ, et al
     Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA2DS2-VASc score in the entire Korean population.
     Int J Cardiol. 2017 Feb 13. pii: S0167-5273(16)34726.
     PubMed     Abstract available
     
     
     
214. GUIMARAES LF, Stone GW, Caixeta A
     Reply: Delayed onset of novel P2Y12 receptor antagonists action post fibrinolysis.
     Int J Cardiol. 2017 Feb 11. pii: S0167-5273(17)30775.
     PubMed    
     
     
     
215. MASUDA K, Ishizu T, Niwa K, Takechi F, et al
     Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.
     Int J Cardiol. 2017 Feb 5. pii: S0167-5273(17)30680.
     PubMed     Abstract available
     
     
     
216. MODI R, Patted SV, Halkati PC, Porwal S, et al
     CHA2DS2-VASc-HSF score - New predictor of severity of coronary artery disease in 2976 patients.
     Int J Cardiol. 2017;228:1002-1006.
     PubMed     Abstract available
     
     
     
217. YUAN X, Du J, Liu Q, Zhang L, et al
     Defining the role of perioperative statin treatment in patients after cardiac surgery: A meta-analysis and systematic review of 20 randomized controlled trials.
     Int J Cardiol. 2017;228:958-966.
     PubMed     Abstract available
     
     
     January 2017
218. VEDOVATI MC, Verdecchia P, Giustozzi M, Molini G, et al
     Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
     Int J Cardiol. 2017 Jan 19. pii: S0167-5273(16)34180.
     PubMed     Abstract available
     
     
     
219. KO D, Thigpen JL, Otis JA, Forster K, et al
     Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
     Int J Cardiol. 2017;227:808-812.
     PubMed     Abstract available
     
     
     
220. SUZUKI M, Takanashi S, Ohshima Y, Nagatomo Y, et al
     Critical potential of early cardiac surgery for infective endocarditis with cardio-embolic strokes.
     Int J Cardiol. 2017;227:222-224.
     PubMed     Abstract available
     
     
     December 2016
221. GUIMARAES LF, Genereux P, Silveira D, Pesaro AE, et al
     P2Y12 receptor inhibition with prasugrel and ticagrelor in STEMI patients after fibrinolytic therapy: Analysis from the SAMPA randomized trial.
     Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34824.
     PubMed     Abstract available
     
     
     
222. MUSCOGIURI G, Annweiler C, Duval G, Karras S, et al
     Vitamin D and cardiovascular disease: From atherosclerosis to myocardial infarction and stroke.
     Int J Cardiol. 2016 Dec 26. pii: S0167-5273(16)34541.
     PubMed     Abstract available
     
     
     
223. KAHLERT P, Hildebrandt HA, Patsalis PC, Al-Rashid F, et al
     No protection of heart, kidneys and brain by remote ischemic preconditioning before transfemoral transcatheter aortic valve implantation: Interim-analysis of a randomized single-blinded, placebo-controlled, single-center trial.
     Int J Cardiol. 2016 Dec 6. pii: S0167-5273(16)33752.
     PubMed     Abstract available
     
     
     November 2016
224. LEE CH, Lin TY, Chang SH, Chen CH, et al
     Body mass index is an independent predictor of major bleeding in non-valvular atrial fibrillation patients taking dabigatran.
     Int J Cardiol. 2016;228:771-778.
     PubMed     Abstract available
     
     
     
225. WYBRANIEC MT, Faryan M, Kusz B, Lasek-Bal A, et al
     CHA2DS2-VASC-AF2 score accurately predicts moderate-to-severe acute neurological dysfunction in the course of first ever ischaemic stroke.
     Int J Cardiol. 2016;228:286-288.
     PubMed    
     
     
     
226. WONG CK
     Simplifying electrocardiographic assessment in STEMI reperfusion management: Pros and cons.
     Int J Cardiol. 2016;227:30-36.
     PubMed     Abstract available
     
     
     
227. SASAI M, Iso Y, Mizukami T, Tomosugi N, et al
     Potential contribution of the hepcidin-macrophage axis to plaque vulnerability in acute myocardial infarction in human.
     Int J Cardiol. 2016;227:114-121.
     PubMed     Abstract available
     
     
     
228. BECATTINI C, Franco L, Beyer-Westendorf J, Masotti L, et al
     Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
     Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33576.
     PubMed     Abstract available
     
     
     
229. ZHOU X, Cao K, Kou S, Qu S, et al
     Usefulness of CHADS2 score for prognostic stratification of patients with coronary artery disease: A systematic review and meta-analysis of cohort studies.
     Int J Cardiol. 2016;228:906-911.
     PubMed     Abstract available
     
     
     
230. ZHU W, Fu L, Ding Y, Huang L, et al
     Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation.
     Int J Cardiol. 2016 Nov 9. pii: S0167-5273(16)33445.
     PubMed     Abstract available
     
     
     
231. GUIMARAES PO, Wojdyla DM, Alexander JH, Thomas L, et al
     Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial.
     Int J Cardiol. 2016 Nov 7. pii: S0167-5273(16)33444.
     PubMed     Abstract available
     
     
     October 2016
232. NAVARESE EP, Kolodziejczak M, Winter MP, Alimohammad A, et al
     Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study.
     Int J Cardiol. 2016 Oct 29. pii: S0167-5273(16)33272.
     PubMed     Abstract available
     
     
     September 2016
233. SCHMIDT M, Ulrichsen SP, Pedersen L, Botker HE, et al
     30-year nationwide trends in incidence of atrial fibrillation in Denmark and associated 5-year risk of heart failure, stroke, and death.
     Int J Cardiol. 2016;225:30-36.
     PubMed     Abstract available
     
     
     
234. CHUGH Y, Faillace RT
     The C of CHADS: Historical perspective and clinical applications for anticoagulation in patients with non valvular atrial fibrillation and congestive heart failure.
     Int J Cardiol. 2016;224:431-436.
     PubMed     Abstract available
     
     
     
235. RUSSO V, Di Napoli L, Bianchi V, Tavoletta V, et al
     A new integrated strategy for direct current cardioversion in non-valvular atrial fibrillation patients using short term rivaroxaban administration: The MonaldiVert real life experience.
     Int J Cardiol. 2016;224:454-455.
     PubMed    
     
     
     
236. INDRARATNA P, Tian DH, Yan TD, Doyle MP, et al
     Transcatheter aortic valve implantation versus surgical aortic valve replacement: A meta-analysis of randomized controlled trials.
     Int J Cardiol. 2016;224:382-387.
     PubMed     Abstract available
     
     
     
237. AKCAY M, Soylu K, Yanik A
     Acute thrombotic left main coronary artery; treatment with low dose slow infusion tPA.
     Int J Cardiol. 2016;224:265-266.
     PubMed    
     
     
     
238. TAKEUCHI D, Inai K, Shinohara T, Nakanishi T, et al
     Blood coagulation abnormalities and the usefulness of D-dimer level for detecting intracardiac thrombosis in adult Fontan patients.
     Int J Cardiol. 2016;224:139-144.
     PubMed     Abstract available
     
     
     August 2016
239. KATZ M, Bosworth HB, Lopes RD, Dupre ME, et al
     A time-series analysis of the relation between unemployment rate and hospital admission for acute myocardial infarction and stroke in Brazil over more than a decade.
     Int J Cardiol. 2016;224:33-36.
     PubMed     Abstract available
     
     
     
240. DZIEWIERZ A, Siudak Z, Tokarek T, Rakowski T, et al
     Determinants of stroke following percutaneous coronary intervention in acute myocardial infarction (from ORPKI Polish National Registry).
     Int J Cardiol. 2016;223:236-238.
     PubMed    
     
     
     
241. SANI M, Ayubi E, Mansori K, Khazaei S, et al
     Predictive ability of HAS-BLED, HEMORR2HAGES, and ATRIA bleeding risk scores in patients with atrial fibrillation: Methodological issues of prediction models.
     Int J Cardiol. 2016;222:949.
     PubMed    
     
     
     
242. HUMBERT X, Roule V, Chequel M, Fedrizzi S, et al
     Non-vitamin K oral anticoagulant treatment in elderly patients with atrial fibrillation and coronary heart disease.
     Int J Cardiol. 2016 Aug 4. pii: S0167-5273(16)31605.
     PubMed     Abstract available
     
     
     
243. HUGO GS, Figueiras-Graillet LM, Anguita M, Marin F, et al
     Oral anticoagulation in octogenarians with atrial fibrillation.
     Int J Cardiol. 2016;223:87-90.
     PubMed     Abstract available
     
     
     
244. BEDEIR K, Giugliano RP, Ramlawi B
     Chronic anticoagulation in non-valvular atrial fibrillation: Where things stand.
     Int J Cardiol. 2016;222:615-619.
     PubMed     Abstract available
     
     
     
245. KIM Y, Lee SH
     Embolic stroke and after-admission atrial fibrillation.
     Int J Cardiol. 2016;222:576-580.
     PubMed     Abstract available
     
     
     
246. ERGUN G, Basaran O, Dogan V, Dogan MM, et al
     Obesity and atrial fibrillation.
     Int J Cardiol. 2016;223:159-160.
     PubMed    
     
     
     
247. ELGENDY IY, Mahmoud AN, Mansoor H, Mojadidi MK, et al
     Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?
     Int J Cardiol. 2016;222:441-447.
     PubMed     Abstract available
     
     
     
248. CANOY D, Cairns BJ, Balkwill A, Wright FL, et al
     Hypertension in pregnancy and risk of coronary heart disease and stroke: A prospective study in a large UK cohort.
     Int J Cardiol. 2016;222:1012-1018.
     PubMed     Abstract available
     
     
     July 2016
249. SAITO I, Yamagishi K, Kokubo Y, Yatsuya H, et al
     Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study.
     Int J Cardiol. 2016;222:281-286.
     PubMed     Abstract available
     
     
     
250. PATZER J, Oqab Z, McIntyre WF, Hopman WM, et al
     Cardiology residents' anticoagulation preferences for stroke prophylaxis in atrial fibrillation patients.
     Int J Cardiol. 2016;223:63-64.
     PubMed    
     
     
     
251. ENGDAHL J, Holmen A, Svennberg E, Friberg L, et al
     Geographic and socio-demographic differences in uptake of population-based screening for atrial fibrillation: The STROKESTOP I study.
     Int J Cardiol. 2016;222:430-435.
     PubMed     Abstract available
     
     
     
252. GARG L, Chen C, Haines DE
     Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination?
     Int J Cardiol. 2016;222:47-50.
     PubMed     Abstract available
     
     
     
253. SENOO K, Lip GY
     Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial.
     Int J Cardiol. 2016;221:379-382.
     PubMed     Abstract available
     
     
     June 2016
254. PAGNESI M, Martino EA, Chiarito M, Mangieri A, et al
     Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis.
     Int J Cardiol. 2016;221:97-106.
     PubMed     Abstract available
     
     
     
255. CHOI EJ, Lee IH, Je NK
     Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era.
     Int J Cardiol. 2016;220:647-652.
     PubMed     Abstract available
     
     
     
256. PALOMAKI A, Kiviniemi T, Mustonen P, Odei C, et al
     Mortality after stroke in patients with paroxysmal and chronic atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2016 Jun 23. pii: S0167-5273(16)31117.
     PubMed     Abstract available
     
     
     
257. XIA SJ, Du X, Li C, Wu JH, et al
     Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
     Int J Cardiol. 2016;220:284-289.
     PubMed     Abstract available
     
     
     
258. ROKOS J, Heger M, Stollberger C, Finsterer J, et al
     Bipolar disorder, ischemic stroke, mitral valve vegetation and recurrent venous thrombosis due to antiphospholipid syndrome despite rivaroxaban.
     Int J Cardiol. 2016;221:383-384.
     PubMed    
     
     
     
259. RICCI RP, Vaccari D, Morichelli L, Zanotto G, et al
     Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
     Int J Cardiol. 2016;219:251-256.
     PubMed     Abstract available
     
     
     
260. COLANTONIO LD, Gamboa CM, Kleindorfer DO, Carson AP, et al
     Stroke symptoms and risk for incident coronary heart disease in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
     Int J Cardiol. 2016;220:122-128.
     PubMed     Abstract available
     
     
     May 2016
261. TONG Y, Cai L, Zhang YW, Lin L, et al
     Role of functional polymorphisms of the IL-10 gene promoter in the risk of ischemic stroke in Chinese Uyghur population: One case-control study.
     Int J Cardiol. 2016;211:58-60.
     PubMed    
     
     
     April 2016
262. RICCI F, Di Castelnuovo A, Savarese G, Perrone Filardi P, et al
     ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure - A network meta-analysis.
     Int J Cardiol. 2016;217:128-134.
     PubMed     Abstract available
     
     
     
263. STOLLBERGER C, Finsterer J, Schneider B
     Is left atrial appendage closure useful for stroke prevention in atrial fibrillation patients with renal failure?
     Int J Cardiol. 2016;216:186-187.
     PubMed    
     
     
     
264. ALBERTS MJ, Peacock WF, Fields LE, Bunz TJ, et al
     Association between once- and twice-daily direct oral anticoagulant adherence in nonvalvular atrial fibrillation patients and rates of ischemic stroke.
     Int J Cardiol. 2016;215:11-13.
     PubMed    
     
     
     
265. XIE XX, Liu P, Wan FY, Lin SG, et al
     Blood pressure lowering and stroke events in type 2 diabetes: A network meta-analysis of randomized controlled trials.
     Int J Cardiol. 2016;208:141-6.
     PubMed    
     
     
     March 2016
266. KOUNIS NG, Grapsas N, Soufras GD, Lianas D, et al
     Clinical and subclinical leaflet thrombosis in bioprosthetic aortic valves: A manifestation of Kounis syndrome?
     Int J Cardiol. 2016;214:86-87.
     PubMed    
     
     
     
267. EFTEKHARI A, Damgaard D, Grove EL
     Fatal stroke following treatment with apixaban in a patient with atrial fibrillation and left atrial appendage thrombus.
     Int J Cardiol. 2016;214:131-132.
     PubMed    
     
     
     
268. WATANABE E, Yamamoto M, Kodama I, Inoue H, et al
     Net clinical benefit of adding aspirin to warfarin in patients with atrial fibrillation: Insights from the J-RHYTHM Registry.
     Int J Cardiol. 2016;212:311-317.
     PubMed     Abstract available
     
     
     
269. COLEMAN CI, Tangirala M, Evers T
     Medication adherence to rivaroxaban and dabigatran for stroke prevention in patients with non-valvular atrial fibrillation in the United States.
     Int J Cardiol. 2016;212:171-173.
     PubMed    
     
     
     
270. TONG Y, Huang X, Wang Z, Han S, et al
     Effects of functional genetic variants in PPARdelta encoding peroxisome proliferator-activated receptor delta on the risk of ischemic stroke in Chinese Han population.
     Int J Cardiol. 2016;207:297-9.
     PubMed    
     
     
     
271. DELLBORG M, Eriksson P
     Randomized trials of closure of persistent foramen ovale (PFO) vs medical therapy for patients with cryptogenic stroke - Effect of lost-to-follow-up and withdrawal of consent.
     Int J Cardiol. 2016;207:308-9.
     PubMed    
     
     
     February 2016
272. YIP HK, Yuen CM, Chen KH, Chai HT, et al
     Tissue plasminogen activator deficiency preserves neurological function and protects against murine acute ischemic stroke.
     Int J Cardiol. 2016;205:133-41.
     PubMed     Abstract available
     
     
     
273. SEO WK, Kang SH, Jung JM, Choi JY, et al
     Novel composite score to predict atrial Fibrillation in acute stroke patients: AF predicting score in acute stroke.
     Int J Cardiol. 2016;209:184-189.
     PubMed     Abstract available
     
     
     
274. MELGAARD L, Gorst-Rasmussen A, Sogaard P, Rasmussen LH, et al
     Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation.
     Int J Cardiol. 2016;209:1-6.
     PubMed     Abstract available
     
     
     
275. LEE YB, Jeong SW, Rhee MY, Leem CH, et al
     Aorta-to-arm pulse wave transit time ratio: Better prediction of coronary artery disease and stroke than pulse wave velocity.
     Int J Cardiol. 2016;204:1-3.
     PubMed    
     
     
     January 2016
276. LEE YJ, Park JK, Uhm JS, Kim JY, et al
     Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy.
     Int J Cardiol. 2016;203:372-8.
     PubMed     Abstract available
     
     
     
277. KEFER J, Tzikas A, Freixa X, Shakir S, et al
     Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
     Int J Cardiol. 2016;207:335-340.
     PubMed     Abstract available
     
     
     
278. PANG J, Zhang Z, Zheng TZ, Bassig BA, et al
     Green tea consumption and risk of cardiovascular and ischemic related diseases: A meta-analysis.
     Int J Cardiol. 2016;202:967-74.
     PubMed     Abstract available
     
     
     
279. MAR PL, Familtsev D, Ezekowitz MD, Lakkireddy D, et al
     Periprocedural management of anticoagulation in patients taking novel oral anticoagulants: Review of the literature and recommendations for specific populations and procedures.
     Int J Cardiol. 2016;202:578-85.
     PubMed     Abstract available
     
     
     November 2015
280. GARG J, Chaudhary R, Krishnamoorthy P, Shah N, et al
     Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
     Int J Cardiol. 2015;203:906-908.
     PubMed    
     
     
     
281. MEYER ML, Jaensch A, Mons U, Breitling LP, et al
     Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: Relevance of routine electrocardiogram.
     Int J Cardiol. 2015;203:1014-1015.
     PubMed    
     
     
     
282. MARCUCCI M, Skjoth F, Lip GY, Iorio A, et al
     A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation.
     Int J Cardiol. 2015;203:785-790.
     PubMed     Abstract available
     
     
     October 2015
283. PALOMAKI A, Mustonen P, Hartikainen JE, Nuotio I, et al
     Strokes after cardioversion of atrial fibrillation - The FibStroke study.
     Int J Cardiol. 2015;203:269-273.
     PubMed    
     
     
     
284. GARGIULO G, Capodanno D, Sannino A, Barbanti M, et al
     New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: A causal or spurious association?
     Int J Cardiol. 2015;203:264-266.
     PubMed    
     
     
     September 2015
285. DURHEIM MT, Cyr DD, Lopes RD, Thomas LE, et al
     Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
     Int J Cardiol. 2015;202:589-594.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stroke is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: